UK Regulator Explains Data Requirements For Converted EU Approvals
New Portal Planned For Information Submission
In another of the many guidances it has issued on medicines regulation in the post-Brexit UK, the MHRA explains the additional information it will need from companies whose EU marketing authorizations are converted into national MAs in January 2021, and the new labeling requirements for those products.
